SCHOTT Pharma Opens State-of-the-art Production Facility in Lukácsháza, Hungary
After EUR 76 million (HUF 28,044 billion) investment and 1.5 years of construction, SCHOTT Pharma opens its newest production facility to support pharma megatrends and market growth for prefillable syringes made of specialty glass
Read More...
Read More...